Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascites.
To four ovarian cancer patients with malignant ascites, 10 KE of OK-432 was intraperitoneally administered four times at 2 day intervals for priming, and 40 KE of OK-432 was given on the 13th day after the first injection for triggering. The changes in blood monocyte and peritoneal macrophage levels and the production of tumor necrosis factor (TNF) by blood mononuclear cells (BMCs) and ascitic lymphoid cells (ALCs) were examined. In the two patients in whom TNF was induced in the ascites, TNF production by BMCs and ALCs was noted during priming. After triggering, increases in both the number of peritoneal macrophages and TNF production by ALCs were noted. In the other two patients, in whom TNF was not detected in the ascites, the ratio of peritoneal macrophages to ALCs did not change throughout the study period, and TNF production by the ALCs was not augmented. These findings suggest that OK-432 can exert a primary effect on both peritoneal macrophages and blood monocytes, and that OK-432 triggering can promote an increase in primed peritoneal macrophages and the release of TNF from these cells.
Mori
H
H
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Itoh
N
N
Yamada
Y
Y
Tamaya
T
T
D001201:Ascites / Q000378:metabolism; D001688:Biological Products / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000032:analysis; D007963:Leukocytes, Mononuclear / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000378:metabolism*; D010844:Picibanil / Q000494:pharmacology*; D011134:Polysaccharides; D012882:Skin Tests; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D001688:Biological Products; D011134:Polysaccharides; D014409:Tumor Necrosis Factor-alpha; D010844:Picibanil; D007371:Interferon-gamma